Showing results for "The Treatment" in Biological Sciences

We are in the midst of a global mental health crisis, and mental illnesses are on the rise. But what causes mental illness? And why are mental health problems so hard to treat? Drawing on decades of research, Harvard psychiatrist Dr. Chris Palmer outlines a revolutionary new understanding that for the first time unites our existing knowledge about mental illness within a single framework: mental disorders are metabolic disorders of the brain. Brain Energy will transform the field of mental health, and the lives of countless people around the world.

Welcome, my name is Dr. Jay Chaplin with Elevating Cancer Treatment! Whether you’re just starting cancer treatment, going through another round, or in remission you’ll find straightforward guidance, like chemo tips, science-based explanations, and debunking myths about cancer. From diagnosis to daily life, we help you navigate cancer treatment with knowledge and support. You are in the right place if you are looking for information on:🏥 cancer surgery, chemotherapy, radiation, cancer immunotherapy, and complementary and alternative medicine🚨 breast cancer, colon cancer, bone ...

Seed treatments are the core of any successful crop. So much has to go right to maximize seeds’ potential and minimize threats. Young plants face pressure from their environment, insects, and several enemies that go unseen by the average eye. Listen to industry experts explore the history, present day and future of agricultural insurance, seed treatments.

On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, we’re all rare, sharing unique insights and experiences that drive innovation and progress. Our ...

Listeners can expect to learn about: • The disease burden and underlying pathophysiology of IgA nephropathy, including the role of endothelin and angiotensin in disease progression • The current IgAN treatment landscape • The response to sparsentan, a dual endothelin angiotensin receptor antagonist, in patients with IgA nephropathy in the phase 3 PROTECT trial